Pharmacokinetic evaluation and In Vitro–In Vivo Correlation (IVIVC) of novel methylene-substituted 3,3′ diindolylmethane (DIM)
Authors:
- 8 February 2012
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 46 (1-2) , 8-16
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Population pharmacokinetics of a propofol bolus administered in patients with major burnsBurns, 2010
- Inhalation Delivery of a Novel Diindolylmethane Derivative for the Treatment of Lung CancerMolecular Cancer Therapeutics, 2010
- Population pharmacokinetics of intravenously and orally administered docetaxel with or without co‐administration of ritonavir in patients with advanced cancerBritish Journal of Clinical Pharmacology, 2010
- Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non–Small Cell Lung CancerClinical Cancer Research, 2009
- Single-Dose Pharmacokinetics and Tolerability of Absorption-Enhanced 3,3′-Diindolylmethane in Healthy SubjectsCancer Epidemiology, Biomarkers & Prevention, 2008
- Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogsCancer Letters, 2008
- 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinaseCarcinogenesis, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Current industrial practices of assessing permeability and P-glycoprotein interactionThe AAPS Journal, 2006
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991